KDL Biotech Ltd. - Research Center
532291 KOPDRUGS Group (Z) BSE data
Add to watchlist
| Results |
Annual
|
| Statement | |
| More |
Annual results in brief
(Rs crore)
| Mar ' 14 | Mar ' 13 | Mar ' 12 | Mar ' 11 | Mar ' 10 | |
|---|---|---|---|---|---|
| Sales | 0.99 | 20.54 | 26.47 | 7.85 | 38.38 |
| Operating profit | -3.56 | -2.81 | -2.13 | -28.19 | -10.12 |
| Interest | 6.86 | 6.86 | 6.77 | 6.67 | 2.83 |
| Gross profit | -10.06 | -9.31 | -8.38 | -18.68 | -11.25 |
| EPS (Rs) | -7.06 | -6.74 | -7.17 | -25.53 | -7.08 |
Annual
results in details
| Mar ' 14 | Mar ' 13 | Mar ' 12 | Mar ' 11 | Mar ' 10 | |
|---|---|---|---|---|---|
| Other income | 0.36 | 0.36 | 0.51 | 0.45 | 1.70 |
| Stock adjustment | - | - | - | 0.43 | 0.16 |
| Raw material | 0.06 | 0.94 | 4.70 | 1.40 | 9.54 |
| Power and fuel | - | - | - | - | - |
| Employee expenses | 2.71 | 8.80 | 9.79 | 9.36 | 14.30 |
| Excise | - | - | - | - | - |
| Admin and selling expenses | - | - | - | - | - |
| Research and development expenses | - | - | - | - | - |
| Expenses capitalised | - | - | - | - | - |
| Other expenses | 1.78 | 13.61 | 14.10 | 24.84 | 24.50 |
| Provisions made | - | - | - | - | - |
| Depreciation | 6.90 | 6.90 | 9.15 | 9.54 | 12.40 |
| Taxation | - | - | - | 7.69 | 0.02 |
| Net profit / loss | -16.96 | -16.21 | -17.24 | -61.35 | -17.01 |
| Extra ordinary item | - | - | 0.46 | -25.44 | 6.66 |
| Prior year adjustments | - | - | -0.17 | - | - |
| Equity capital | 24.04 | 24.04 | 24.04 | 24.04 | 24.04 |
| Equity dividend rate | - | - | - | - | - |
| Agg.of non-prom. shares (Lacs) | 74.85 | 74.85 | 74.85 | 74.85 | 74.85 |
| Agg.of non promotoholding (%) | 31.14 | 31.14 | 31.14 | 31.14 | 31.14 |
| OPM (%) | -359.25 | -13.67 | -8.03 | -359.22 | -26.36 |
| GPM (%) | -746.22 | -44.54 | -31.07 | -225.10 | -28.06 |
| NPM (%) | -1,258.39 | -77.56 | -63.89 | -739.33 | -42.43 |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis